GSK and Pfizer form new world-leading consumer healthcare joint venture
LONDON: GlaxoSmithKline (GSK) has completed its transaction with Pfizer to combine their consumer healthcare businesses into a world-leading Joint Venture (JV). GSK has a controlling equity interest of 68% and Pfizer has an equity interest of 32% in the Joint…